• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成素样蛋白 8 在脂肪酸餐后分配过程中差异调节 ANGPTL3 和 ANGPTL4。

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.

机构信息

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN.

Division of Cardiovascular Medicine, Department of Medicine Solna, Karolinska Institutet Karolinska University Hospital Solna, Stockholm, Sweden.

出版信息

J Lipid Res. 2020 Aug;61(8):1203-1220. doi: 10.1194/jlr.RA120000781. Epub 2020 Jun 2.

DOI:10.1194/jlr.RA120000781
PMID:32487544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7397750/
Abstract

Angiopoietin-like protein (ANGPTL)8 has been implicated in metabolic syndrome and reported to regulate adipose FA uptake through unknown mechanisms. Here, we studied how complex formation of ANGPTL8 with ANGPTL3 or ANGPTL4 varies with feeding to regulate LPL. In human serum, ANGPTL3/8 and ANGPTL4/8 complexes both increased postprandially, correlated negatively with HDL, and correlated positively with all other metabolic syndrome markers. ANGPTL3/8 also correlated positively with LDL-C and blocked LPL-facilitated hepatocyte VLDL-C uptake. LPL-inhibitory activity of ANGPTL3/8 was >100-fold more potent than that of ANGPTL3, and LPL-inhibitory activity of ANGPTL4/8 was >100-fold less potent than that of ANGPTL4. Quantitative analyses of inhibitory activities and competition experiments among the complexes suggested a model in which localized ANGPTL4/8 blocks the LPL-inhibitory activity of both circulating ANGPTL3/8 and localized ANGPTL4, allowing lipid sequestration into fat rather than muscle during the fed state. Supporting this model, insulin increased ANGPTL3/8 secretion from hepatocytes and ANGPTL4/8 secretion from adipocytes. These results suggest that low ANGPTL8 levels during fasting enable ANGPTL4-mediated LPL inhibition in fat tissue to minimize adipose FA uptake. During feeding, increased ANGPTL8 increases ANGPTL3 inhibition of LPL in muscle via circulating ANGPTL3/8, while decreasing ANGPTL4 inhibition of LPL in adipose tissue through localized ANGPTL4/8, thereby increasing FA uptake into adipose tissue. Excessive caloric intake may shift this system toward the latter conditions, possibly predisposing to metabolic syndrome.

摘要

血管生成素样蛋白 (ANGPTL)8 与代谢综合征有关,并据报道通过未知机制调节脂肪 FA 的摄取。在这里,我们研究了 ANGPTL8 与 ANGPTL3 或 ANGPTL4 形成复合物的方式如何随进食而变化,从而调节 LPL。在人血清中,ANGPTL3/8 和 ANGPTL4/8 复合物在进食后均增加,与 HDL 呈负相关,与所有其他代谢综合征标志物呈正相关。ANGPTL3/8 还与 LDL-C 呈正相关,并阻断 LPL 促进的肝细胞 VLDL-C 摄取。ANGPTL3/8 对 LPL 的抑制活性比 ANGPTL3 高 100 多倍,而 ANGPTL4/8 对 LPL 的抑制活性比 ANGPTL4 低 100 多倍。对这些复合物的抑制活性进行定量分析和竞争实验表明,一种模型可以解释,局部 ANGPTL4/8 阻断了循环中的 ANGPTL3/8 和局部的 ANGPTL4 的 LPL 抑制活性,从而使脂肪组织在进食状态下将脂质隔离起来而不是肌肉。支持该模型的是,胰岛素增加了肝细胞分泌的 ANGPTL3/8 和脂肪细胞分泌的 ANGPTL4/8。这些结果表明,禁食期间低水平的 ANGPTL8 使脂肪组织中的 ANGPTL4 介导的 LPL 抑制作用最小化,以最大限度地减少脂肪 FA 的摄取。进食时,增加的 ANGPTL8 通过循环中的 ANGPTL3/8 增加 ANGPTL3 对 LPL 的抑制作用,同时通过局部的 ANGPTL4/8 减少脂肪组织中 ANGPTL4 对 LPL 的抑制作用,从而增加 FA 摄取到脂肪组织中。过量的热量摄入可能会使该系统向后者转变,从而可能导致代谢综合征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/5f66c5f09eaf/1203fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/b29498bd3710/1203fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/ac67bac37c2f/1203fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/584999102dd4/1203fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/3d93e144b403/1203fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/ca0bc202cd4b/1203fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/89fb6e883035/1203fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/3d72df79522d/1203fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/766401cc9a3a/1203fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/5f66c5f09eaf/1203fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/b29498bd3710/1203fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/ac67bac37c2f/1203fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/584999102dd4/1203fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/3d93e144b403/1203fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/ca0bc202cd4b/1203fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/89fb6e883035/1203fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/3d72df79522d/1203fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/766401cc9a3a/1203fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce0/7397750/5f66c5f09eaf/1203fig9.jpg

相似文献

1
Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.血管生成素样蛋白 8 在脂肪酸餐后分配过程中差异调节 ANGPTL3 和 ANGPTL4。
J Lipid Res. 2020 Aug;61(8):1203-1220. doi: 10.1194/jlr.RA120000781. Epub 2020 Jun 2.
2
Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.血管生成素样蛋白 4(E40K)和 ANGPTL4/8 复合物与 ANGPTL4 相比,其脂蛋白脂肪酶抑制活性随温度降低。
Biochem Biophys Res Commun. 2021 Jan 1;534:498-503. doi: 10.1016/j.bbrc.2020.11.053. Epub 2020 Nov 22.
3
Angiopoietin-like proteins and postprandial partitioning of fatty acids.血管生成素样蛋白与餐后脂肪酸分配
Curr Opin Lipidol. 2022 Feb 1;33(1):39-46. doi: 10.1097/MOL.0000000000000798.
4
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.血管生成素样蛋白 8:一种调节甘油三酯代谢的多功能蛋白。
Curr Opin Lipidol. 2024 Apr 1;35(2):58-65. doi: 10.1097/MOL.0000000000000910. Epub 2023 Nov 14.
5
Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.遗传模拟分析揭示了 ANGPTL3-ANGPTL8 复合物和 ANGPTL4 靶向的特定脂肪酶。
J Lipid Res. 2023 Jan;64(1):100313. doi: 10.1016/j.jlr.2022.100313. Epub 2022 Nov 11.
6
Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes.在糖尿病患者中,ANGPTL3、4 和 8 与脂质和葡萄糖代谢标志物的关系。
PLoS One. 2021 Jul 22;16(7):e0255147. doi: 10.1371/journal.pone.0255147. eCollection 2021.
7
Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue.禁食可诱导人脂肪组织中 ANGPTL4 的产生并降低 LPL 活性。
Mol Metab. 2020 Oct;40:101033. doi: 10.1016/j.molmet.2020.101033. Epub 2020 Jun 3.
8
Increased plasma and adipose tissue levels of ANGPTL8/Betatrophin and ANGPTL4 in people with hypertension.高血压患者血浆和脂肪组织中 ANGPTL8/Betatrophin 和 ANGPTL4 水平升高。
Lipids Health Dis. 2018 Mar 1;17(1):35. doi: 10.1186/s12944-018-0681-0.
9
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.ANGPTL3、ANGPTL4 和 ANGPTL8 对脂蛋白代谢的调节。
Am J Physiol Endocrinol Metab. 2021 Oct 1;321(4):E493-E508. doi: 10.1152/ajpendo.00195.2021. Epub 2021 Aug 2.
10
Decoding the role of angiopoietin-like protein 4/8 complex-mediated plasmin generation in the regulation of LPL activity.解析血管生成素样蛋白4/8复合物介导的纤溶酶生成在脂蛋白脂肪酶活性调节中的作用。
J Lipid Res. 2023 Oct;64(10):100441. doi: 10.1016/j.jlr.2023.100441. Epub 2023 Sep 4.

引用本文的文献

1
Secretion and transfer of adipose lipoprotein lipase utilizes neutral sphingomyelinase 2 generated exosomes.脂肪脂蛋白脂肪酶的分泌和转运利用中性鞘磷脂酶2产生的外泌体。
bioRxiv. 2025 Aug 1:2025.07.31.665751. doi: 10.1101/2025.07.31.665751.
2
Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids.瑞他鲁肽治疗后循环中血管生成素样蛋白3/8(ANGPTL3/8)浓度的降低与血脂的降低情况相似。
Diabetes Obes Metab. 2025 Oct;27(10):5985-5995. doi: 10.1111/dom.16661. Epub 2025 Jul 29.
3
ANGPTL4: A Comprehensive Review of 25 Years of Research.

本文引用的文献

1
GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.GPIHBP1 和脂蛋白脂肪酶,共同参与血浆甘油三酯代谢。
Cell Metab. 2019 Jul 2;30(1):51-65. doi: 10.1016/j.cmet.2019.05.023.
2
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.单克隆抗体抑制血管生成素样蛋白 3 可降低高甘油三酯血症中的甘油三酯。
Circulation. 2019 Aug 6;140(6):470-486. doi: 10.1161/CIRCULATIONAHA.118.039107. Epub 2019 Jun 27.
3
ANGPTL4 in Metabolic and Cardiovascular Disease.ANGPTL4 在代谢和心血管疾病中的作用。
血管生成素样蛋白4:25年研究综述
Cancers (Basel). 2025 Jul 16;17(14):2364. doi: 10.3390/cancers17142364.
4
Targeting triglyceride-rich lipoproteins in cardiovascular disease.针对心血管疾病中富含甘油三酯的脂蛋白
Nat Med. 2025 Jul 24. doi: 10.1038/s41591-025-03845-x.
5
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome.解析代谢综合征中饮食诱导的肥胖和糖脂功能障碍的复杂性。
Diabetol Metab Syndr. 2025 Jul 22;17(1):292. doi: 10.1186/s13098-025-01837-y.
6
Research advances in current drugs targeting hyperlipidemia (Review).当前治疗高脂血症药物的研究进展(综述)
Mol Med Rep. 2025 Oct;32(4). doi: 10.3892/mmr.2025.13623. Epub 2025 Jul 19.
7
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial.在混合性高脂血症患者中使用单克隆抗体靶向血管生成素样蛋白3/8复合物:一项1期试验。
Nat Med. 2025 Jul 10. doi: 10.1038/s41591-025-03830-4.
8
Clinical Value of Circulating Angiopoietin-like Protein 8/Betatrophin Levels in Patients with Acute Pancreatitis.循环血管生成素样蛋白8/β-促胰岛素分泌素水平在急性胰腺炎患者中的临床价值
Medicina (Kaunas). 2025 Apr 11;61(4):708. doi: 10.3390/medicina61040708.
9
Plasma angiopoietin-like protein 4 as a novel biomarker predicting 10-year mortality in a community-based population: a longitudinal cohort study.血浆血管生成素样蛋白4作为预测社区人群10年死亡率的新型生物标志物:一项纵向队列研究
Arch Med Sci. 2024 Jun 6;21(1):51-59. doi: 10.5114/aoms/189504. eCollection 2025.
10
ANGPTL3/8 is an atypical unfoldase that regulates intravascular lipolysis by catalyzing unfolding of lipoprotein lipase.血管生成素样蛋白3/8是一种非典型解折叠酶,通过催化脂蛋白脂肪酶的解折叠来调节血管内脂解作用。
Proc Natl Acad Sci U S A. 2025 Mar 25;122(12):e2420721122. doi: 10.1073/pnas.2420721122. Epub 2025 Mar 20.
Trends Mol Med. 2019 Aug;25(8):723-734. doi: 10.1016/j.molmed.2019.05.010. Epub 2019 Jun 21.
4
Evolution of Hominin Polyunsaturated Fatty Acid Metabolism: From Africa to the New World.从非洲到新世界:人科动物多不饱和脂肪酸代谢的演变。
Genome Biol Evol. 2019 May 1;11(5):1417-1430. doi: 10.1093/gbe/evz071.
5
Lipoprotein lipase is active as a monomer.脂蛋白脂肪酶以单体形式发挥活性。
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6319-6328. doi: 10.1073/pnas.1900983116. Epub 2019 Mar 8.
6
ANGPTL4 gene E40K variation protects against obesity-associated dyslipidemia in participants with obesity.血管生成素样蛋白4(ANGPTL4)基因E40K变异可预防肥胖参与者的肥胖相关血脂异常。
Obes Sci Pract. 2018 Dec 26;5(1):83-90. doi: 10.1002/osp4.311. eCollection 2019 Feb.
7
On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.关于血管生成素样蛋白 8 控制脂蛋白脂肪酶活性的机制。
J Lipid Res. 2019 Apr;60(4):783-793. doi: 10.1194/jlr.M088807. Epub 2019 Jan 27.
8
Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans.肌间脂肪组织直接调节人类骨骼肌的胰岛素敏感性。
Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E866-E879. doi: 10.1152/ajpendo.00243.2018. Epub 2019 Jan 8.
9
Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition.绘制脂蛋白脂肪酶 (LPL)-血管生成素样蛋白 4 (ANGPTL4) 相互作用的位点为 LPL 抑制作用提供了机制上的深入了解。
J Biol Chem. 2019 Feb 22;294(8):2678-2689. doi: 10.1074/jbc.RA118.005932. Epub 2018 Dec 27.
10
CRISPR/Cas9-mediated knockout suppresses plasma triglyceride concentrations and adiposity in rats.CRISPR/Cas9 介导的基因敲除可降低大鼠的血浆甘油三酯浓度和肥胖程度。
J Lipid Res. 2018 Sep;59(9):1575-1585. doi: 10.1194/jlr.M082099. Epub 2018 Jul 24.